113 related articles for article (PubMed ID: 2419740)
21. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P
J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
[TBL] [Abstract][Full Text] [Related]
22. Responsiveness of lymphoid precursors to polyclonal B-cell activators.
Gronowicz E; Coutinho A
Scand J Immunol; 1975 Sep; 4(5-6):429-37. PubMed ID: 52177
[TBL] [Abstract][Full Text] [Related]
23. Modulation of expression of class II MHC and CD40 molecules in murine B cells by various muramyl dipeptides.
Cohen LY; Bahr GM; Darcissac EC; Parant MA
Cell Immunol; 1996 Apr; 169(1):75-84. PubMed ID: 8612298
[TBL] [Abstract][Full Text] [Related]
24. Target cells for immunomodulatory action of muramyl dipeptide.
Dozmorov IM; Bagaeva LV; Kuzin II; Svirshchevskaya EV
Biomed Sci; 1991; 2(2):193-7. PubMed ID: 1772973
[TBL] [Abstract][Full Text] [Related]
25. LPS regulation of the immune response: separate mechanisms for murine B cell activation by lipid A (direct) and polysaccharide (macrophage-dependent) derived from Bacteroides LPS.
Williamson SI; Wannemuehler MJ; Jirillo E; Pritchard DG; Michalek SM; McGhee JR
J Immunol; 1984 Nov; 133(5):2294-300. PubMed ID: 6332842
[TBL] [Abstract][Full Text] [Related]
26. [Increasing the sensitivity of murine splenic cells to interleukin-2 after in vivo exposure to lipopolysaccharide, muramyl dipeptide and concanavalin A].
Rakhmilevich AL; Obernikhin SS; Rakhimova MS
Antibiot Khimioter; 1989 Nov; 34(11):839-41. PubMed ID: 2633700
[TBL] [Abstract][Full Text] [Related]
27. Combined effects of synthetic lipid A analogs or bacterial lipopolysaccharide with glucosaminylmuramyl dipeptide on antitumor activity against Meth A fibrosarcoma in mice.
Shimizu T; Iwamoto Y; Yanagihara Y; Ikeda K; Achiwa K
Int J Immunopharmacol; 1992 Nov; 14(8):1415-20. PubMed ID: 1464473
[TBL] [Abstract][Full Text] [Related]
28. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.
Le Contel C; Temime N; Charron DJ; Parant MA
J Immunol; 1993 May; 150(10):4541-9. PubMed ID: 8482846
[TBL] [Abstract][Full Text] [Related]
29. Induction of antibodies directed against self and altered-self determinants by a synthetic adjuvant, muramyl dipeptide and some of its derivatives.
Löwy I; Leclerc C; Chedid L
Immunology; 1980 Mar; 39(3):441-50. PubMed ID: 6160092
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramylpeptides and bacterial lipopolysaccharides with bovine serum albumin.
Ogawa T; Kotani S; Shimauchi H
Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):19-26. PubMed ID: 3702542
[TBL] [Abstract][Full Text] [Related]
31. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
Heymer B; Finger H; Wirsing CH
Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of liposome-incorporation on liver macrophage activating potencies of rough lipopolysaccharide, lipid A, and muramyl dipeptide. Differences in susceptibility to lysosomal enzymes.
Daemen T; Veninga A; Dijkstra J; Scherphof G
J Immunol; 1989 Apr; 142(7):2469-74. PubMed ID: 2926140
[TBL] [Abstract][Full Text] [Related]
33. Immunological activities of muramyl peptides.
Bahr GM; Chedid L
Fed Proc; 1986 Oct; 45(11):2541-4. PubMed ID: 3489642
[TBL] [Abstract][Full Text] [Related]
34. Catabolic effects of muramyl dipeptide on rabbit chondrocytes.
Ikebe T; Iribe H; Hirata M; Yanaga F; Koga T
Arthritis Rheum; 1990 Dec; 33(12):1801-6. PubMed ID: 2261002
[TBL] [Abstract][Full Text] [Related]
35. Synergism between muramyl dipeptide and lipopolysaccharide in the inhibition of glycosaminoglycan synthesis in cultured rat costal chondrocytes.
Ikebe T; Hirata M; Yanaga F; Koga T
Ann Rheum Dis; 1993 Jan; 52(1):32-6. PubMed ID: 8427511
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of B-cell stimulation by muramyl dipeptide through a mechanism not involving interleukin 1 or increased Ca2+ mobilization or protein kinase C activation.
Dziarski R
Cell Immunol; 1988 Jan; 111(1):10-27. PubMed ID: 2448043
[TBL] [Abstract][Full Text] [Related]
37. Role of Muramyl Dipeptide in Lipopolysaccharide-Mediated Biological Activity and Osteoclast Activity.
Kitaura H; Ishida M; Kimura K; Sugisawa H; Kishikawa A; Shima K; Ogawa S; Qi J; Shen WR
Anal Cell Pathol (Amst); 2018; 2018():8047610. PubMed ID: 29666781
[TBL] [Abstract][Full Text] [Related]
38. [Activation of the production of cytotoxic factors by mouse spleen cells exposed to the combined action of lipopolysaccharide and muramyl dipeptide in vitro].
Rakhmilevich AL; Rakhimova MS
Biull Eksp Biol Med; 1988 Apr; 105(4):483-6. PubMed ID: 3359036
[TBL] [Abstract][Full Text] [Related]
39. Activation of murine B cells with Salmonella typhimurium mitogen (STM), lipopolysaccharide (LPS), and dextran sulfate (DxS). I. Cell-cycle analysis and induction of cytoplasmic immunoglobulin.
Brooks KH; Vitetta ES
J Mol Cell Immunol; 1987; 3(4):215-9. PubMed ID: 2473769
[TBL] [Abstract][Full Text] [Related]
40. Effect of a synthetic adjuvant on the induction of primary immune responses in T cell-depleted spleen cultures.
Watson J; Whitlock C
J Immunol; 1978 Jul; 121(1):383-9. PubMed ID: 307582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
